The AI in Retail Conference returns to New York on January 12, bringing senior retail and AI leaders together to ...

NEWARK, CA / ACCESS Newswire / January 7, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today ...

Banking giant JP Morgan has won a sex discrimination case against a female analyst who claimed she was paid less for doing ...

Apple has been on the hunt for a replacement card issuer ever since Goldman Sachs decided to abandon its push into retail ...

J.P. Morgan said on Monday it launched a new advisory unit to serve a select group of clients and widen their access to ...

Taiwan Semiconductor Manufacturing stock has gained from it being the dominant AI chip manufacturer. Intel won’t challenge it ...

Phase 1/2a study with lead Radio-DARPin MP0712 initiated; first patient dosing expected Q1 2026, initial data anticipated in 2026Full imaging and dosimetry data from MP0712 compassionate care program ...

One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for ...

The super-sized gathering of the biopharma universe known as JPM is important, but it’s not going to make or break the year ...

J.P. Morgan's top defensive-growth idea, with shares expected to re-rate up "on robust EBITDA accretion from renewable ...

32 Biosciences revealed its plan to launch a $40 million Series A at this year’s J.P Morgan Healthcare conference, to advance ...

J.P. Morgan’s top pick energy stocks for 2026 have secular growth drivers, robust balance sheets, and exposure to ...